Challa Sneha, Chiu Calvin, Jegede Ayobambo, Idiodi Ivan, Aliyu Mikail, Okoli Chioma, Dimowo Shakede, Tijani Aminat, Nmadu Awawu Grace, Diallo Rodio, Liu Jenny, Omoluabi Elizabeth
University of California, San Francisco, Institute for Health & Aging, School of Nursing, Box 0646, 490 Illinois St., 12th Floor, San Francisco, CA, 94158, USA.
AkenaPlus Health, F Road #18, Citec Estate, Airport Road, Abuja, Nigeria.
BMC Womens Health. 2025 Aug 21;25(Suppl 1):399. doi: 10.1186/s12905-025-03946-2.
Self-injection (SI) of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is a self-care intervention (drugs, diagnostics, or devices that can be provided mostly outside the health system) implemented across Nigeria. Per national guidelines, first-time DMPA-SC users can obtain units for SI after two in-person training visits. Success of self-care interventions, the option for SI included, depends on local policies and individual providers to create an enabling environment. Thus, we aimed to 1) assess providers' fidelity to Ministry of Health protocols; 2) assess the extent of bias in fidelity; and 3) to asses client-centeredness.
Eight mystery client actors portrayed an older, married woman or a younger, unmarried woman without DMPA-SC experience. They sought contraception, including DMPA-SC for SI, at 30 public and 30 private facilities. A total of 120 interactions were planned (two per facility-one by each profile). Immediately following their interactions, actors completed a debrief survey about their experiences. Using responses from these debrief surveys, we described key actor-reported outcomes (providers' fidelity to Ministry of Health protocols for SI dispensing, SI training, and supporting contraceptive decision-making). We also examined objective and subjective client-centeredness outcomes. We assessed bias in fidelity and client-centeredness through bivariate tests for differences by actor profile (younger/unmarried vs older/married) and facility type (health facility vs pharmacy/PPMV).
Fidelity to dispensing guidelines (i.e., refusing DMPA-SC units for SI) differed by facility type (χ = 12.4, p-value < 0.001). Descriptively, pharmacists/PPMVs more often broke with protocol and were willing to dispense DMPA-SC units. Similarly, fidelity to Ministry of Health training guidelines on DMPA-SC for SI differed by facility type (χ = 9.9, p-value = 0.007). Client-centeredness outcomes (e.g., being asked about and feeling treated differently based on age and marital status) were found to differ by actor profile. Descriptively, more of the younger, unmarried profile actors reported these outcomes compared to older, married profile actors.
Willingness to dispense DMPA-SC for SI differed by facility type but not by client profile. However, younger, unmarried profile actors experienced more scrutiny from providers. These findings indicate a need for clarifying service provision protocols to ensure an enabling environment for women's access to and use of self-injectable contraception.
皮下注射长效醋酸甲羟孕酮(DMPA-SC)的自我注射(SI)是一种在尼日利亚各地实施的自我保健干预措施(可主要在卫生系统之外提供的药物、诊断方法或设备)。根据国家指南,首次使用DMPA-SC的用户在进行两次面对面培训后可获得用于自我注射的药物。自我保健干预措施(包括自我注射选项)的成功取决于当地政策和个体提供者营造有利环境。因此,我们旨在:1)评估提供者对卫生部方案的遵循程度;2)评估遵循程度中的偏差程度;3)评估以客户为中心的程度。
八名神秘客户扮演者分别扮演一名没有DMPA-SC使用经验的老年已婚妇女或年轻未婚妇女。她们在30家公立和30家私立机构寻求避孕措施,包括用于自我注射的DMPA-SC。总共计划进行120次互动(每家机构两次——每种角色各一次)。互动结束后,扮演者立即完成了一份关于她们经历的汇报调查。利用这些汇报调查的回复,我们描述了关键的扮演者报告结果(提供者对卫生部自我注射药物分发、自我注射培训和支持避孕决策方案的遵循程度)。我们还检查了客观和主观的以客户为中心的结果。我们通过按扮演者角色(年轻/未婚与年长/已婚)和机构类型(医疗机构与药店/计划生育服务点)进行差异的双变量检验,评估遵循程度和以客户为中心程度中的偏差。
对分发指南的遵循程度(即拒绝提供用于自我注射的DMPA-SC药物)因机构类型而异(χ = 12.4,p值 < 0.001)。从描述来看,药剂师/计划生育服务点更常违反方案,愿意分发DMPA-SC药物。同样,对卫生部关于DMPA-SC自我注射培训指南的遵循程度也因机构类型而异(χ = 9.9,p值 = 0.007)。以客户为中心的结果(例如,被询问以及因年龄和婚姻状况而感觉受到不同对待)因扮演者角色而异。从描述来看,与年长已婚的扮演者相比,更多年轻未婚的扮演者报告了这些结果。
提供用于自我注射的DMPA-SC的意愿因机构类型而异,而非因客户角色而异。然而,年轻未婚的扮演者受到提供者更多的审查。这些发现表明需要明确服务提供方案,以确保为妇女获取和使用自我注射避孕措施创造有利环境。